Ferring Pharmaceuticals Inc. et al v. Serenity Pharmaceuticals, LLC et al

  1. September 16, 2020

    SDNY Judge Says She's 'DONE' With Serenity, Ferring IP Case

    Manhattan's top federal judge on Wednesday rejected a request by Serenity Pharmaceuticals to amend a recent judgment in a patent case that went in favor of rival drugmaker Ferring Pharmaceuticals, with the seemingly exasperated judge saying she is "DONE" with the case.

  2. August 21, 2020

    Ferring Gets Rival's Patents Scrapped In Zoom Trial Win

    Manhattan's top federal judge handed Ferring Pharmaceuticals a decisive win Friday in its patent showdown with rival Serenity after a Zoom trial last month, with the judge blasting Serenity's founder for taking Ferring's research for his overly broad and generic patents.

  3. July 23, 2020

    Serenity Faces Skeptical Judge As IP Trial With Ferring Wraps

    Drugmaker Serenity appears to be facing an uphill battle in its Zoom trial with rival Ferring over patents related to a nighttime urination medication, with the presiding New York federal judge telling Serenity during Thursday's closing arguments that it had "a problem."

  4. July 17, 2020

    COVID-19 IP Catch-Up: Delays, Masks & Ducks

    Even as a remote patent trial finishes up in New York, judges in Delaware are pushing dates back and Apple is asking for further delays in Texas. On the trademark end, 3M has reported back on its litigation campaign over N95 masks. Here are some recent intellectual property updates tied to the coronavirus outbreak that you may have missed.

  5. July 15, 2020

    Serenity Expert Defends IP As Zoom Trial Testimony Wraps

    The Zoom patent showdown between drugmakers Ferring and Serenity in New York federal court finished live testimony on Wednesday with a professor of pharmaceutical sciences testifying for Serenity that its patents related to a nighttime urination medication are not so broad as to be invalid.

  6. July 14, 2020

    Infringement Has Judge's Eye In Ferring-Serenity Remote Trial

    The New York federal judge overseeing a Zoom bench trial between drugmakers Ferring and Serenity over a pair of patents relating to nighttime urination medication told the parties Tuesday that she finds Serenity's infringement allegations "infinitely more interesting" than Ferring's claims to invalidate the patents.

  7. July 13, 2020

    Ex-Ferring Exec Says He Had Rival's Drug Innovation First

    Ferring's former chief scientific officer for urology on Monday testified in a New York federal bench trial, held via Zoom, that rival drugmaker Serenity's co-founder's "alleged" invention of a nighttime urination medication was based on the Ferring scientist's prior discoveries.

  8. July 10, 2020

    COVID-19 IP Catch-Up: NY Trial Finally Starts, Texas Holds Off

    The COVID-19 pandemic has caused a drug patent trial in New York to go remote and again delayed a media streaming patent trial in Texas. Meanwhile, 3M settled a fraud suit tied to its N95 masks, and Jeff Dunham received pushback from a company selling face masks with his image. Here are some recent intellectual property updates tied to the outbreak that you may have missed.

  9. July 09, 2020

    Ferring Experts Attack Serenity Patents In SDNY Zoom Trial

    The remote bench trial between Ferring Pharmaceuticals and its rival Serenity took another turn into new territory Thursday when experts for Ferring testified from Europe before a New York federal judge, telling her that Serenity's patents are based on shoddy data and don't apply to Ferring's nighttime urination medication.

  10. July 07, 2020

    Serenity Says Ferring Owes $389K In SDNY Zoom IP Trial

    Drugmaker Serenity told a New York federal judge Tuesday that rival Ferring owes it $388,700 for its alleged patent infringement during the second day of a Zoom bench trial, which also saw Serenity's co-founder questioned about whether he was the sole inventor of the nighttime urination medication patents at issue.